Related Experiment Videos
High-dose pentobarbital pharmacokinetics in hypothermic brain-injured children
Insights
Hypothermia significantly reduces pentobarbital clearance and distribution in children, impacting its effectiveness for managing elevated intracranial pressure. This study explores pentobarbital pharmacokinetics in critically ill children.
Area of Science:
- Pediatric critical care medicine
- Clinical pharmacology
- Neuroscience
Background:
- Pentobarbital is used to reduce cerebral metabolism in patients with elevated intracranial pressure.
- Hypothermia is sometimes employed as an adjunct therapy in these patients.
- Understanding pentobarbital pharmacokinetics in hypothermic pediatric patients is crucial for optimizing treatment.
Purpose of the Study:
- To investigate the pharmacokinetics of pentobarbital in children with conditions causing elevated intracranial pressure, particularly those who are hypothermic.
- To compare pentobarbital clearance and distribution in hypothermic children to normothermic adults.
Main Methods:
- Pharmacokinetic analysis of pentobarbital in 11 pediatric patients (Reye syndrome, hypoxic encephalopathy, acute head injury).
- Nine patients were hypothermic (<32°C).
- Comparison with historical data from normothermic adult volunteers.
Main Results:
- Total systemic clearance and volume of distribution of pentobarbital were significantly reduced in hypothermic children compared to normothermic adults.
- Pentobarbital elimination half-life did not differ significantly between groups.
- Reduced clearance may be due to hypothermia-induced enzyme inhibition and hepatic dysfunction.
- Limited distribution may result from altered body composition or reduced blood flow.
Conclusions:
- Hypothermia and hepatic dysfunction in pediatric patients significantly alter pentobarbital pharmacokinetics.
- Reduced clearance and distribution of pentobarbital in hypothermic children may enhance its efficacy in reducing cerebral metabolism.
- These findings have implications for barbiturate therapy in managing elevated intracranial pressure in critically ill children.
Abstract:
The pharmacokinetics of pentobarbital were examined in 11 children with Reye syndrome, hypoxic encephalopathy, or acute head injury. Nine of these patients were hypothermic (less than 32 degrees C). The total systemic clearance and volume of distribution at steady state of pentobarbital were significantly reduced in these patients when compared to previous data in normothermic adult volunteers following intravenous doses of pentobarbital. Pentobarbital elimination half-life was not significantly different from control values. The diminished systemic clearance of pentobarbital may result from decreases in intrinsic enzyme activity that accompany hypothermia, as well as hepatic dysfunction in patients with Reye syndrome. Less extensive distribution of pentobarbital is likely the result of either differences in body fat composition or hypothermia-induced decreases in regional blood flow. The reduced clearance and distribution of pentobarbital may partially explain the enhanced reduction in cerebral metabolism that occurs on addition of hypothermia to barbiturate therapy in patients with elevated intracranial pressure.